SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-115783
Filing Date
2005-05-26
Accepted
2005-05-26 17:18:20
Documents
7
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 383830
2 AMENDMENT TO WAIVER LETTER & SECURED CONVERTIBLE MINIMUM BORROWING NOTE SERIES B dex101.htm EX-10.1 7481
3 AMENDMENT TO SECURED CONVERTIBLE TERM NOTE dex102.htm EX-10.2 6088
4 SECTION 302 -- CEO CERTIFICATION dex311.htm EX-31.1 8487
5 SECTION 302 -- CFO CERTIFICATION dex312.htm EX-31.2 8398
6 SECTION 906 -- CEO CERTIFICATION dex321.htm EX-32.1 4050
7 SECTION 906 -- CFO CERTIFICATION dex322.htm EX-32.2 3823
  Complete submission text file 0001193125-05-115783.txt   423526
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

IRS No.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30975 | Film No.: 05860877
SIC: 3826 Laboratory Analytical Instruments